Annual Working Capital
-$3.81 M
-$28.95 M-115.14%
July 31, 2024
Summary
- As of February 7, 2025, BCTX annual working capital is -$3.81 million, with the most recent change of -$28.95 million (-115.14%) on July 31, 2024.
- During the last 3 years, BCTX annual working capital has fallen by -$61.05 million (-106.65%).
- BCTX annual working capital is now -106.65% below its all-time high of $57.24 million, reached on July 31, 2021.
Performance
BCTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$3.23 M
+$7.04 M+184.85%
October 31, 2024
Summary
- As of February 7, 2025, BCTX quarterly working capital is $3.23 million, with the most recent change of +$7.04 million (+184.85%) on October 31, 2024.
- Over the past year, BCTX quarterly working capital has increased by +$4.46 million (+363.11%).
- BCTX quarterly working capital is now -94.36% below its all-time high of $57.24 million, reached on July 31, 2021.
Performance
BCTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BCTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -115.1% | +363.1% |
| 3 y3 years | -106.7% | -93.2% |
| 5 y5 years | -294.6% | -93.2% |
BCTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -106.7% | at low | -93.2% | +184.8% |
| 5 y | 5-year | -106.7% | at low | -94.4% | +184.8% |
| alltime | all time | -106.7% | at low | -94.4% | +184.8% |
BriaCell Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $3.23 M(-184.9%) |
| Jul 2024 | -$3.81 M(-115.1%) | -$3.81 M(+210.1%) |
| Apr 2024 | - | -$1.23 M(-115.7%) |
| Jan 2024 | - | $7.82 M(-55.0%) |
| Oct 2023 | - | $17.36 M(-31.0%) |
| Jul 2023 | $25.15 M(-39.3%) | $25.15 M(-10.6%) |
| Apr 2023 | - | $28.12 M(-15.5%) |
| Jan 2023 | - | $33.27 M(-10.7%) |
| Oct 2022 | - | $37.25 M(-10.0%) |
| Jul 2022 | $41.41 M(-27.7%) | $41.41 M(-9.7%) |
| Apr 2022 | - | $45.86 M(-3.9%) |
| Jan 2022 | - | $47.71 M(-14.0%) |
| Oct 2021 | - | $55.48 M(-3.1%) |
| Jul 2021 | $57.24 M(-1646.1%) | $57.24 M(+177.5%) |
| Apr 2021 | - | $20.63 M(-653.9%) |
| Jan 2021 | - | -$3.72 M(+7.6%) |
| Oct 2020 | - | -$3.46 M(-6.5%) |
| Jul 2020 | -$3.70 M(+283.7%) | -$3.70 M(+23.8%) |
| Apr 2020 | - | -$2.99 M(+19.1%) |
| Jan 2020 | - | -$2.51 M(+134.6%) |
| Oct 2019 | - | -$1.07 M(+10.9%) |
| Jul 2019 | -$964.80 K(-279.5%) | -$964.80 K(-477.8%) |
| Apr 2019 | - | $255.40 K(-125.5%) |
| Jan 2019 | - | -$1.00 M(+2369.5%) |
| Oct 2018 | - | -$40.60 K(-107.6%) |
| Jul 2018 | $537.60 K(-28.2%) | $537.60 K(-73.8%) |
| Apr 2018 | - | $2.05 M(+1152.2%) |
| Jan 2018 | - | $164.10 K(-76.3%) |
| Oct 2017 | - | $693.30 K(-7.3%) |
| Jul 2017 | $748.30 K(-4.6%) | $748.30 K(-52.5%) |
| Apr 2017 | - | $1.58 M(+15.9%) |
| Jan 2017 | - | $1.36 M(-15.6%) |
| Oct 2016 | - | $1.61 M(+105.4%) |
| Jul 2016 | $784.70 K(-30.5%) | $784.70 K(-30.8%) |
| Apr 2016 | - | $1.13 M(+127.9%) |
| Jan 2016 | - | $497.20 K(-39.4%) |
| Oct 2015 | - | $820.20 K(-27.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2015 | $1.13 M(<-9900.0%) | $1.13 M(-25.0%) |
| Apr 2015 | - | $1.50 M(-7.6%) |
| Jan 2015 | - | $1.63 M(+189.1%) |
| Oct 2014 | - | $563.00 K(<-9900.0%) |
| Jul 2014 | -$1100.00(-100.1%) | -$1100.00(-100.1%) |
| Apr 2014 | - | $891.30 K(-4.2%) |
| Jan 2014 | - | $930.80 K(-19.8%) |
| Oct 2013 | - | $1.16 M(-17.5%) |
| Jul 2013 | $1.41 M(-23.8%) | $1.41 M(-9.5%) |
| Apr 2013 | - | $1.56 M(-9.1%) |
| Jan 2013 | - | $1.71 M(+10.0%) |
| Oct 2012 | - | $1.56 M(-15.8%) |
| Jul 2012 | $1.85 M(-58.8%) | $1.85 M(-45.2%) |
| Apr 2012 | - | $3.37 M(-4.9%) |
| Jan 2012 | - | $3.54 M(-3.2%) |
| Oct 2011 | - | $3.66 M(-18.3%) |
| Jul 2011 | $4.48 M(+231.8%) | $4.48 M(-36.2%) |
| Apr 2011 | - | $7.02 M(+561.7%) |
| Jan 2011 | - | $1.06 M(-13.9%) |
| Oct 2010 | - | $1.23 M(-8.8%) |
| Jul 2010 | $1.35 M(+91.0%) | $1.35 M(-11.5%) |
| Apr 2010 | - | $1.52 M(+165.7%) |
| Jan 2010 | - | $573.90 K(-3.6%) |
| Oct 2009 | - | $595.30 K(-15.7%) |
| Jul 2009 | $706.50 K(+107.5%) | $706.50 K(+102.5%) |
| Apr 2009 | - | $348.90 K(+95.5%) |
| Jan 2009 | - | $178.50 K(-18.2%) |
| Oct 2008 | - | $218.10 K(-35.9%) |
| Jul 2008 | $340.40 K(-23.8%) | $340.40 K(-20.2%) |
| Apr 2008 | - | $426.60 K(-5.8%) |
| Jan 2008 | - | $453.10 K(-8.7%) |
| Oct 2007 | - | $496.20 K(+11.1%) |
| Jul 2007 | $446.70 K(+521.3%) | $446.70 K(-3.2%) |
| Apr 2007 | - | $461.40 K(+4.5%) |
| Jan 2007 | - | $441.60 K(-6.0%) |
| Oct 2006 | - | $469.90 K |
| Jul 2006 | $71.90 K | - |
FAQ
- What is BriaCell Therapeutics annual working capital?
- What is the all time high annual working capital for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual working capital year-on-year change?
- What is BriaCell Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly working capital year-on-year change?
What is BriaCell Therapeutics annual working capital?
The current annual working capital of BCTX is -$3.81 M
What is the all time high annual working capital for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual working capital is $57.24 M
What is BriaCell Therapeutics annual working capital year-on-year change?
Over the past year, BCTX annual working capital has changed by -$28.95 M (-115.14%)
What is BriaCell Therapeutics quarterly working capital?
The current quarterly working capital of BCTX is $3.23 M
What is the all time high quarterly working capital for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly working capital is $57.24 M
What is BriaCell Therapeutics quarterly working capital year-on-year change?
Over the past year, BCTX quarterly working capital has changed by +$4.46 M (+363.11%)